New device could help save preterm babies by spotting oxygen drops
NCT ID NCT05278247
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new light-based monitor (NIRS) that checks oxygen levels in the abdomen of preterm infants. Researchers want to see if it works reliably and safely on 50 babies born before 35 weeks. If it does, it could help doctors quickly detect life-threatening gut problems like NEC.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NIRS device (near-infrared spectroscopy monitor)
What this could lead to
If successful, this could provide a safer, more reliable way to monitor oxygen levels in preterm infants, helping doctors catch dangerous conditions earlier.
What could go wrong
This is an early-stage study with only 50 infants, focused on device performance rather than health outcomes. The device may not work as expected or may cause skin irritation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••